Literature DB >> 2376866

Suppression of cellular immune activity following severe head injury.

K B Quattrocchi1, E H Frank, C H Miller, J P MacDermott, L Hein, L Frey, F C Wagner.   

Abstract

Infection is a major cause of morbidity following multiple traumatic and head injury. Although immunosuppression has been demonstrated after multiple traumatic injury, the effects of head injury on immune function have not been thoroughly investigated. In a prospective study of 10 severely head-injured patients, in vitro and in vivo parameters of cellular immune activity were assessed. In vitro measurements of lymphocyte surface antigen expression following mitogen stimulation were made serially over a 3-week period in 10 patients with severe head injury. The control group consisted of 20 healthy subjects. Phenotyping of peripheral blood lymphocytes (PBLs) was performed following incubation with and without mitogens. Phenotypes were determined by flow cytometry using monoclonal antibodies (MABs) to T lymphocyte subsets and the alpha subunit of interleukin 2 (IL-2) receptors. In vivo cellular immune function was determined by measuring patient responses to delayed-type hypersensitivity (DTH) skin testing within 24 h of injury. When head-injured patients were compared to controls, PBLs incubated in the presence of phytohemagglutinin (PHA) demonstrated a decrease in cells marking as T cells (p = 0.005), helper-inducer T cells (p = 0.001), and in the number of IL-2 receptor-bearing cells (p = 0.001). The functional ability of these lymphocyte subpopulations to proliferate in the presence of PHA was significantly suppressed within 24 h of injury and normalized within 3 weeks of injury. DTH skin testing to Candida, mumps, trichophyton, and PPD antigens was performed within 24 h of injury and resulted in anergic responses in all 10 patients when measured at 24, 48, and 72 h following administration. The overall infection rate was 60%, with the majority of infections occurring within the first 4 days following injury. The results of this study indicate that severe head injury results in suppression of cellular immune function with a corresponding high rate of infection. The possible significance of the decrease in the percentage of helper-inducer T cells and in the number of cells bearing IL-2 receptors following mitogen stimulation is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2376866     DOI: 10.1089/neu.1990.7.77

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  10 in total

1.  Risk of pneumonia in central nervous system injury with alcohol intake: a meta-analysis.

Authors:  Chunming Sun; Liang Shen; Xuetao Li; Chuanjin Liu; Youxin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

3.  Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function.

Authors:  Sarah J Doran; Rebecca J Henry; Kari Ann Shirey; James P Barrett; Rodney M Ritzel; Wendy Lai; Jorge C Blanco; Alan I Faden; Stefanie N Vogel; David J Loane
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

4.  Effect of an immune-enhancing diet on lymphocyte in head-injured rats: what is the role of arginine?

Authors:  Djamel Hamani; Christine Charrueau; Marie-José Butel; Valérie Besson; Linda Belabed; Ioannis Nicolis; Servane Le Plénier; Catherine Marchand-Leroux; Catherine Marchand-Leromp; Jean-Claude Chaumeil; Luc Cynober; Christophe Moinard
Journal:  Intensive Care Med       Date:  2007-04-11       Impact factor: 17.440

Review 5.  Central nervous system injury-induced immune suppression.

Authors:  Eric A Sribnick; Phillip G Popovich; Mark W Hall
Journal:  Neurosurg Focus       Date:  2022-02       Impact factor: 4.047

Review 6.  The duality of the inflammatory response to traumatic brain injury.

Authors:  P M Lenzlinger; M C Morganti-Kossmann; H L Laurer; T K McIntosh
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

Review 7.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

Review 8.  Nosocomial infections and immunity: lesson from brain-injured patients.

Authors:  Tomasz Dziedzic; Agnieszka Slowik; Andrzej Szczudlik
Journal:  Crit Care       Date:  2004-02-19       Impact factor: 9.097

Review 9.  Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus.

Authors:  Jon Hazeldine; Janet M Lord; Antonio Belli
Journal:  Front Neurol       Date:  2015-11-05       Impact factor: 4.003

10.  Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.

Authors:  Alex P Di Battista; Shawn G Rhind; Michael G Hutchison; Syed Hassan; Maria Y Shiu; Kenji Inaba; Jane Topolovec-Vranic; Antonio Capone Neto; Sandro B Rizoli; Andrew J Baker
Journal:  J Neuroinflammation       Date:  2016-02-16       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.